Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NasdaqGS:XMTR
NasdaqGS:XMTRTrade Distributors

Xometry (XMTR): Persistent Losses Challenge Optimism on Expected 99% Annual Earnings Growth

Xometry (XMTR) remains unprofitable, with net losses rising at an annual rate of 2.3% over the past five years and no meaningful progress on profit margins. Despite persistent losses, revenue is forecast to increase by 14.8% per year, which would outpace the broader US market's 10.5% growth. Earnings are projected to jump 99% annually, with profitability expected within three years. Investors attracted to Xometry's rapid top-line growth and the promise of a turnaround must weigh this optimism...
NYSE:BOW
NYSE:BOWInsurance

Bowhead Specialty Holdings (BOW): Net Margin Rises to 10.1% Reinforcing Bullish Growth Narratives

Bowhead Specialty Holdings (BOW) posted an impressive set of headline numbers, with earnings forecast to grow at 23.5% per year, well above the US market average of 16%, and revenue projected to rise 19.3% annually compared to the broader market’s 10.5%. Net profit margin improved to 10.1% from last year’s 7.6%, signaling a clear strengthening in profitability. With earnings quality described as high and expectations set for robust growth, investors are likely to focus on the company's...
NasdaqGS:BVS
NasdaqGS:BVSMedical Equipment

Bioventus (BVS): $17.3M One-Time Loss Raises Questions About Quality of New Profitability

Bioventus (BVS) recently swung to profitability in the past year, despite an average earnings decline of 16.6% per year over the last five years. The bottom line was affected by a non-recurring loss of $17.3 million for the twelve months ending September 27, 2025. Although revenue is forecast to grow at 6.1% annually, this pace trails the broader US market's 10.5% average. Trading at $7.55, the stock sits well below its estimated fair value of $17.96 and also below analyst targets. Its high...
NasdaqGS:DRVN
NasdaqGS:DRVNConsumer Services

Driven Brands (DRVN) Trading at 1x Sales Ratio Highlights Discount Versus Peers Heading Into Earnings

Driven Brands Holdings (DRVN) remains unprofitable, with losses accelerating at an average rate of 48.1% per year over the past five years. However, analysts expect earnings to grow by 56.02% annually, projecting the company will achieve profitability within the next three years. This outlook stands above market averages. Revenue is forecast to grow 4% per year, which is slower than the 10.5% US market average, but the company’s valuation continues to attract attention as shares trade well...
NYSE:ADT
NYSE:ADTConsumer Services

ADT (ADT) Margin Expansion Reinforces Value Narrative, Offsets Concerns on Financial Position

ADT (ADT) reported a net profit margin of 12.8%, up from 11% the previous year, highlighting a notable improvement in profitability. While the company posted 23.3% earnings growth for the most recent year, this is below its impressive five-year annual average of 67.7%. With shares trading at $8.08, well under the estimated fair value of $19.86, investors are weighing the appeal of rising margins and an attractive valuation against concerns over ADT’s less favorable financial position. See our...
NasdaqGM:DAVE
NasdaqGM:DAVEConsumer Finance

Dave (DAVE) Net Profit Margin Climbs to 29.8%, Reinforcing Bullish Community Narratives

Dave (DAVE) posted a net profit margin of 29.8%, jumping from 12.9% last year, as revenue is projected to grow at 15% annually, outpacing the US market’s 10.5% average. Over the past year, earnings soared 255.6%, far exceeding the company’s already impressive five-year average of 43.4% annual growth. With high-quality earnings, improved margins, and momentum on both the revenue and profit fronts, investors are likely to zero in on these operational gains as a sign of sustained business...
NYSE:PAY
NYSE:PAYDiversified Financial

Paymentus (PAY): Margin Uptick Reinforces High-Growth Narrative, But Valuation Remains a Sticking Point

Paymentus Holdings (PAY) posted net profit margins of 5.3%, a slight uptick from last year's 5.2%. Over the past five years, earnings have surged at an impressive 57.4% annual rate, but the latest annual earnings growth of 47% fell short of this pace. Looking ahead, analysts expect earnings to grow 28.1% per year and revenue to expand 19.6% annually. Both figures outpace the broader US market, yet shares trade well above DCF-based estimates with a price-to-earnings ratio of 76.1x. See our...
NasdaqGS:TSAT
NasdaqGS:TSATTelecom

Telesat (TSAT) Losses Accelerate 54% Annually, Challenging Bullish Revenue Growth Narrative

Telesat (TSAT) remains unprofitable, with losses accelerating at an average rate of 54.1% a year over the past five years. Despite the red ink, the company’s revenue is forecast to grow 23.6% annually, outpacing the US market’s 10.5% projection. While top-line expansion is impressive, TSAT’s net profit margin has yet to improve and the company is expected to stay unprofitable for at least the next three years, putting sustained pressure on investor confidence. See our full analysis for...
TSX:EFR
TSX:EFROil and Gas

Energy Fuels (TSX:EFR): Heavy Losses Persist, High Valuation Tests Growth Narrative Ahead of Profitability

Energy Fuels (TSX:EFR) remains unprofitable, with losses having accelerated by 12.2% per year over the last five years. Shares trade at a steep Price-to-Sales Ratio of 49.9x, which is significantly higher than both the Canadian Oil and Gas industry average of 2.6x and its peer average of 14.2x. Despite recent share price volatility and dilution, consensus forecasts point to annual earnings growth of 70.14% and revenue growth of 38.8%, with profitability expected in the next three years. See...
NasdaqCM:AHCO
NasdaqCM:AHCOHealthcare

AdaptHealth (AHCO) Profitability Marks Turnaround, Challenging Bearish Valuation Narratives

AdaptHealth (AHCO) recently turned profitable, with its net profit margin shifting notably over the past year. Despite a -16.2% average annual earnings growth over the last five years, forecasts now call for earnings to grow at 23.1% per year, outpacing the broader US market’s 16%. While revenue is expected to rise 7.3% per year in the coming period, which trails the US average, high earnings quality and significant near-term profit growth are clear upside drivers for investors who see value...
NYSE:GPN
NYSE:GPNDiversified Financial

Global Payments (GPN) Net Margin Tops Expectations, Reinforcing Bullish Narratives on Profit Quality

Global Payments (GPN) posted a net profit margin of 16.2%, up from 13.8% a year ago, and earnings have grown at an impressive 24% per year over the past five years, with a standout 34.4% gain in the last year alone. While revenue and projected annual earnings are expected to grow at a slower pace than the broader US market, the company’s high earnings quality and forward profit growth continue to draw attention as shares trade below estimates of fair value and at a Price-To-Earnings ratio of...
NYSE:MED
NYSE:MEDPersonal Products

Medifast (MED) Profit Margin Plunges to 0.06%, Undermining Recovery Narratives

Medifast (MED) is facing a tough outlook, with both revenue and earnings forecast to decline sharply over the next three years. Revenue is expected to decrease by 12.5% per year, and earnings are projected to fall by 146.7% annually, following a recent year in which net profit margins slipped to just 0.06%, down from 1.1% last year. The company also recorded a one-off loss of $12.5 million in the last twelve months, adding extra pressure to already weakening earnings. In fact, average annual...